Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $81.33 Consensus Price Target from Analysts
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price target […]
More Stories
Short Interest in Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY) Drops By 58.1%
Industria de Diseño Textil, S.A. (OTCMKTS:IDEXY – Get Free Report) was the target of a large decrease in short interest...
VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL) Short Interest Update
VanEck Fallen Angel High Yield Bond ETF (NASDAQ:ANGL – Get Free Report) saw a large decline in short interest during...
BTC Digital Ltd. (NASDAQ:BTCT) Short Interest Down 59.0% in December
BTC Digital Ltd. (NASDAQ:BTCT – Get Free Report) saw a large drop in short interest during the month of December....
CarMax, Inc. (NYSE:KMX) SVP Sells $853,000.00 in Stock
CarMax, Inc. (NYSE:KMX – Get Free Report) SVP Jon G. Daniels sold 10,000 shares of CarMax stock in a transaction...
David L. Duvall Sells 4,500 Shares of Core Molding Technologies, Inc. (NYSEAMERICAN:CMT) Stock
Core Molding Technologies, Inc. (NYSEAMERICAN:CMT – Get Free Report) CEO David L. Duvall sold 4,500 shares of Core Molding Technologies...
Short Interest in iLearningEngines, Inc. (NASDAQ:AILEW) Drops By 70.2%
iLearningEngines, Inc. (NASDAQ:AILEW – Get Free Report) was the target of a significant drop in short interest in December. As...